000300821 001__ 300821
000300821 005__ 20251005022853.0
000300821 0247_ $$2doi$$a10.1186/s12916-025-04052-8
000300821 0247_ $$2pmid$$apmid:40335963
000300821 0247_ $$2altmetric$$aaltmetric:177144205
000300821 037__ $$aDKFZ-2025-00935
000300821 041__ $$aEnglish
000300821 082__ $$a610
000300821 1001_ $$0P:(DE-He78)6c325c717056d7ccd38066629f7dff6b$$aMandic, Marko$$b0$$eFirst author$$udkfz
000300821 245__ $$aAssociation of childhood-to-adulthood body size change with cancer risk: UK Biobank prospective cohort.
000300821 260__ $$aLondon$$bBioMed Central$$c2025
000300821 3367_ $$2DRIVER$$aarticle
000300821 3367_ $$2DataCite$$aOutput Types/Journal article
000300821 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1746708470_30
000300821 3367_ $$2BibTeX$$aARTICLE
000300821 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300821 3367_ $$00$$2EndNote$$aJournal Article
000300821 500__ $$a#EA:C070#LA:C070#
000300821 520__ $$aWhile excess weight in adulthood and childhood has been associated with increased cancer risk, the link between body size change from childhood to adulthood and cancer risk requires further investigation. We aimed to examine the associations of childhood-to-adulthood body size change with the risk of obesity-related cancers.We used data from the UK Biobank, a prospective population-based cohort study. The main exposure was childhood-to-adulthood body size change, constructed from self-reported body size at age 10 (categories: thinner, average, and plumper than average) and measured body mass index (BMI) at recruitment (normal weight, overweight, and obesity). Primary outcome was obesity-related cancer (13 different cancer types).Among 448,936 participants (mean [SD] age, 56.2 [8.1] years; 240,023 were female [53.5%]) and during a median follow-up of 11.7 years (interquartile range [10.9-12.4]), 21,289 incident obesity-related cancer cases were recorded. Most participants were either overweight (42.6%) or had obesity (24.4%) at recruitment, while only a minority (16.0%) reported to have been plumper than average at age 10. Having a larger body size in childhood was strongly associated with having overweight or obesity in adulthood. Compared to participants with average childhood and normal adulthood body size, participants with overweight or obesity in adulthood had a significantly increased risk of obesity-related cancers, regardless of the childhood body size (adjusted hazard ratios ranged from 1.15 [95% CI, 1.06-1.24] to 1.61 [95% CI, 1.50-1.73]). The strength of the association was mostly determined by adulthood BMI, and similar patterns were observed for colorectal, endometrial, kidney, pancreatic, and esophageal cancer. However, a larger body size in childhood was associated with a lower risk of postmenopausal breast cancer (adjusted hazard ratio, 0.86 [95% CI, 0.79-0.93]).While larger body size in childhood predisposes individuals to overweight and obesity in adulthood, maintaining a healthy weight in adulthood may help mitigate the risk of obesity-related cancers. Our findings highlight the importance of preventing and reducing overweight and obesity in adulthood for primary cancer prevention.
000300821 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000300821 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300821 650_7 $$2Other$$aObesity; Overweight; Body mass index; Cancer
000300821 7001_ $$0P:(DE-He78)a15e13b5e2dfc276ddddbf7505023951$$aSafizadeh, Fatemeh$$b1$$udkfz
000300821 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b2$$udkfz
000300821 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b3$$udkfz
000300821 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4$$eLast author$$udkfz
000300821 773__ $$0PERI:(DE-600)2131669-7$$a10.1186/s12916-025-04052-8$$gVol. 23, no. 1, p. 268$$n1$$p268$$tBMC medicine$$v23$$x1741-7015$$y2025
000300821 8767_ $$8SN-2025-00915-b$$92025-08-27$$d2025-10-01$$eAPC$$jZahlung erfolgt
000300821 909CO $$ooai:inrepo02.dkfz.de:300821$$popenCost$$pOpenAPC$$pVDB
000300821 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c325c717056d7ccd38066629f7dff6b$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000300821 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a15e13b5e2dfc276ddddbf7505023951$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000300821 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300821 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000300821 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000300821 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000300821 9141_ $$y2025
000300821 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC MED : 2022$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:34:47Z
000300821 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:34:47Z
000300821 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-04-10T15:34:47Z
000300821 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bBMC MED : 2022$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-05
000300821 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-05
000300821 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000300821 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000300821 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
000300821 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
000300821 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000300821 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000300821 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000300821 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000300821 980__ $$ajournal
000300821 980__ $$aVDB
000300821 980__ $$aI:(DE-He78)C070-20160331
000300821 980__ $$aI:(DE-He78)HD01-20160331
000300821 980__ $$aUNRESTRICTED
000300821 980__ $$aAPC